M&G Investment Management LTD Beam Therapeutics Inc. Transaction History

M&G Investment Management LTD

  • $28.2 Trillion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$68.02 - $99.06 $442,742 - $644,781
-6,509 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$84.37 - $133.6 $381,774 - $604,540
-4,525 Reduced 41.01%
6,509 $566,000
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $707,500 - $1.42 Million
11,034 New
11,034 $1.42 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email